Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

CHEMOURS (NYSE: CC): Kaplan Fox & Kilsheimer LLP is Investigating The Chemours Company for Possible Violations of Federal Securities Laws

NEW YORK, NY - (NewMediaWire) - March 13, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).  Click Here to Join Investigation.

If you acquired Chemours securities and would like to discuss our investigation, please click here or contact us by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.

On February 13, 2024, after the market close, Chemours issued a press release announcing that the Company was delaying the release of Q4 and full year 2023 financial results as the Company evaluates its internal control over financial reporting as of December 31, 2023.  The Company also stated that “[t]he Company’s Audit Committee also needs additional time to complete a related internal review.”

Following this news, the price of Chemours stock fell $3.85 per share, about 12.6%, to close at $26.64 per share.

Then, on February 28, 2024, after the market close, Chemours issued a press release announcing that it had placed three executives, including the Company’s CEO and CFO, on administrative leave pending the completion of the internal review being overseen by the Audit Committee of the Board of Directors with the assistance of independent outside counsel.  Additionally, the Company’s February 28, 2024 press release states that “the Company is evaluating one or more potential material weaknesses in its internal control over financial reporting as of December 31, 2023 with respect to maintaining effective controls related to the control environment, including the effectiveness of the ‘tone at the top’ set by certain members of senior management. . . .”

Following this news, the price of Chemours stock fell $9.05 per share, or 31.5%, to close at $19.67 per share on February 29, 2024.

WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.  With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.  Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.  For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

If you have any questions about this investigation, please contact:

Pamela A. Mayer

KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003

E-mail: pmayer@kaplanfox.com

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax:  (415) 772-4707
E-mail: lking@kaplanfox.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.